Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

957
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
957
Spare Receptors01:30

Spare Receptors

4.5K
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
4.5K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

4.1K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.1K
Radical Reactivity: Nucleophilic Radicals01:16

Radical Reactivity: Nucleophilic Radicals

2.6K
Radicals adjacent to electron-donating groups are called nucleophilic radicals. These radicals readily react with electrophilic alkenes. The SOMO–LUMO interactions are the driving force for the reaction, where the high-energy SOMO of the electron-rich, nucleophilic radicals interacts with the low-energy LUMO of the electron-deficient, electrophilic alkenes. Such SOMO–LUMO interactions are the basis of reactive radical traps, affecting the selectivity in radical reactions. For...
2.6K
Radical Reactivity: Electrophilic Radicals01:02

Radical Reactivity: Electrophilic Radicals

2.4K
Radicals adjacent to electron‐withdrawing groups are called electrophilic radicals. These radicals readily react with nucleophilic alkenes. For example, the malonate radical, in which the radical center is flanked by two electron‐withdrawing groups, reacts readily with butyl vinyl ether, which consists of an electron‐donating oxygen substituent. The reaction between electrophilic malonate radical and nucleophilic vinyl ether is favored because the radical has a...
2.4K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

894
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
894

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Qualitative Analysis of Telemedicine Use Among Urban and Rural Patients With Urologic Malignancies.

JU open plus·2026
Same author

Predicting Private Equity Acquisition of Urology Practices by the Social Vulnerability Index.

Urology·2026
Same author

Survivor-identified barriers and facilitators to acute phase recovery following radical cystectomy.

Urologic oncology·2026
Same author

Genomic diversity of culturable <i>Paraburkholderia</i> and <i>Burkholderia</i> species isolated from Bornean rainforest rhizosphere.

Microbial genomics·2026
Same author

Patient Preferences for Treatment of Intermediate-risk Prostate Cancer: A Discrete Choice Experiment.

Urology·2026
Same author

An opportunity to save? SBRT is less costly than IMRT for intermediate-risk prostate cancer.

Urologic oncology·2025
Same journal

Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy in the Era of Lesion-focused Sampling.

European urology focus·2026
Same journal

Should Male Pattern Baldness Be Considered in Prostate Cancer Risk Assessment? A Systematic Review and Meta-analysis.

European urology focus·2026
Same journal

A Core Outcome Set for Localized Renal Cell Cancer (L-RCC-COS).

European urology focus·2026
Same journal

Reply to Emre Karabay's Letter to the Editor re: Ritter Manuel, Stein Johannes, Barber Neil, et al. WATER III: A Prospective, Partially Randomized Trial of Aquablation Therapy Versus Transurethral Laser Enucleation of the Prostate for Treatment of Lower Urinary Tract Symptoms. Eur Urol Focus 2026;12:266-74.

European urology focus·2026
Same journal

Radioligand Therapy for Prostate Cancer - A Clinical Consultation Guide.

European urology focus·2026
Same journal

Postoperative Pelvic Lymph Node Radiation Therapy in Lymph Node-Positive Prostate Cancer and Mortality Risk.

European urology focus·2026
See all related articles

Related Experiment Video

Updated: Jan 23, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.1K

A Radical Proposition: Opioid-sparing Prostatectomy.

Katherine M Theisen1, Benjamin J Davies1

  • 1Urology Department, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

European Urology Focus
|June 25, 2019
PubMed
Summary
This summary is machine-generated.

Optimizing radical prostatectomy recovery involves managing patient expectations and prioritizing non-opioid pain relief. Utilizing regional anesthesia, multimodal analgesia, and scheduled non-opioid medications significantly reduces opioid dependence post-surgery.

More Related Videos

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.9K
Free Radicals in Chemical Biology: from Chemical Behavior to Biomarker Development
14:22

Free Radicals in Chemical Biology: from Chemical Behavior to Biomarker Development

Published on: April 15, 2013

20.7K

Related Experiment Videos

Last Updated: Jan 23, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.1K
Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.9K
Free Radicals in Chemical Biology: from Chemical Behavior to Biomarker Development
14:22

Free Radicals in Chemical Biology: from Chemical Behavior to Biomarker Development

Published on: April 15, 2013

20.7K

Area of Science:

  • Urology
  • Anesthesiology
  • Pain Management

Background:

  • Radical prostatectomy is increasingly an outpatient procedure with improving recovery times.
  • Effective pain management is crucial for enhancing postoperative recovery and minimizing opioid use.
  • Patient education regarding perioperative expectations is vital for successful outcomes.

Purpose of the Study:

  • To evaluate strategies for improving postoperative recovery after radical prostatectomy.
  • To assess the efficacy of non-opioid pain management alternatives in reducing opioid exposure.
  • To provide guidance on optimizing pain control and patient expectations.

Main Methods:

  • Preoperative counseling on expectations and non-opioid pain management.
  • Implementation of preoperative regional pain blocks.
  • Intraoperative multimodal analgesia and scheduled non-opioid medications.
  • Postoperative administration of acetaminophen and non-steroidal anti-inflammatory drugs.

Main Results:

  • Non-opioid alternatives, including regional blocks and multimodal analgesia, can significantly limit perioperative opioid exposure.
  • Scheduled non-opioid pain medications contribute to reduced reliance on narcotics.
  • Liberal use of acetaminophen and NSAIDs at discharge may obviate the need for opioid prescriptions.

Conclusions:

  • A comprehensive approach combining preoperative education, regional anesthesia, intraoperative multimodal analgesia, and scheduled non-opioid medications enhances recovery after radical prostatectomy.
  • This strategy effectively minimizes opioid use and may eliminate the need for narcotic prescriptions upon discharge.
  • Optimizing pain management with non-opioid alternatives is key to improving the patient experience and recovery trajectory.